MUCINEX
Live / Registered — Registered (as of 21 Jul 2026)
What this means for you
Registered since 21 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Jul 2032: the §8 declaration of use).
Record
- Serial number
- 98499792
- Registration number
- 8356755
- Mark type
- Design + words
- Filed
- 15 Apr 2024
- Published for opposition
- 19 Nov 2024
- Registered
- 21 Jul 2026
- Next maintenance filing
- §8 declaration of use, due by 21 Jul 2032 (grace period to 21 Jan 2033)
- Attorney of record
- Mark Lerner, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds
Owner
- RB Health (US) LLC, Parsippany, NJ, US
- RB Health (US) LLC, Parsippany, NJ, US
- RB Health (US) LLC, Parsippany, NJ, US
Prosecution history
- 21 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 30 Jun 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Jun 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Jun 2026 — USE AMENDMENT FILED
- 29 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 11 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2025 — SOU EXTENSION 2 GRANTED
- 10 Dec 2025 — SOU EXTENSION 2 FILED
- 10 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2025 — SOU EXTENSION 1 GRANTED
- 17 Jun 2025 — SOU EXTENSION 1 FILED
- 09 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL